Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134076) titled 'Clinical efficacy of leflunomide combined with telmisartan in patients with early diabetes and renal disease and its effect on immunity and inflammation' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chongqing Yubei District People's Hospital
Condition:
Early diabetes Kidney disease
Intervention:
control group:Oral telmisartan 40mg qd treatment on the basis of standard treatment, with continuous treatment for 6 months
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-03-05
Target Sample Size: control group:45;Treatment group:45;
Cou...